Search research articles
Contact Us
Filters
Showing results (211-220 of 250) with videos related to
Page
of 25
Sort By:
Physical Review Letters
|
February 21, 2025
Refined Topology of the N=20 Island of Inversion with High Precision Mass Measurements of ^{31-33}Na and ^{31-35}Mg
E M Lykiardopoulou, C Walls, J Bergmann, et al.
Physical Review Letters
|
June 27, 2025
Precision Mass Measurements Reveal Low Neutron Pairing in Tin beyond N=82 and Its Impact on Stellar Nucleosynthesis
A Mollaebrahimi, C Walls, T Dickel, et al.
Science (New York, N.Y.)
|
July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E Bowen, Amin Addetia, Ha V Dang, et al.
Biorxiv : the Preprint Server for Biology
|
April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Eclinicalmedicine
|
July 26, 2022
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Science (New York, N.Y.)
|
July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Cell
|
March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Journal of the American Academy of Dermatology
|
May 12, 2020
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease
Colleen K Gabel, Emily Nguyen, Ryan Karmouta, et al.
Biorxiv : the Preprint Server for Biology
|
January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Biorxiv : the Preprint Server for Biology
|
August 2, 2024
Computationally designed mRNA-launched protein nanoparticle vaccines
Grace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 250) with videos related to
Sort By:
Page
of 25
Physical Review Letters
|
February 21, 2025
Refined Topology of the N=20 Island of Inversion with High Precision Mass Measurements of ^{31-33}Na and ^{31-35}Mg
E M Lykiardopoulou, C Walls, J Bergmann, et al.
Physical Review Letters
|
June 27, 2025
Precision Mass Measurements Reveal Low Neutron Pairing in Tin beyond N=82 and Its Impact on Stellar Nucleosynthesis
A Mollaebrahimi, C Walls, T Dickel, et al.
Science (New York, N.Y.)
|
July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E Bowen, Amin Addetia, Ha V Dang, et al.
Biorxiv : the Preprint Server for Biology
|
April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Eclinicalmedicine
|
July 26, 2022
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Science (New York, N.Y.)
|
July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Cell
|
March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Journal of the American Academy of Dermatology
|
May 12, 2020
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease
Colleen K Gabel, Emily Nguyen, Ryan Karmouta, et al.
Biorxiv : the Preprint Server for Biology
|
January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Biorxiv : the Preprint Server for Biology
|
August 2, 2024
Computationally designed mRNA-launched protein nanoparticle vaccines
Grace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
Page
of 25